Terms: = Colorectal cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Prognosis
148 results:
1. Targeted Mass Spectrometry Analyses of Somatic Mutations in colorectal cancer Specimens Using Differential Ion Mobility.
Wu Z; Bonneil É; Belford M; Boeser C; Dunyach JJ; Thibault P
J Proteome Res; 2024 Feb; 23(2):644-652. PubMed ID: 38153093
[TBL] [Abstract] [Full Text] [Related]
2. Small molecular inhibitors for KRAS-mutant cancers.
Wu X; Song W; Cheng C; Liu Z; Li X; Cui Y; Gao Y; Li D
Front Immunol; 2023; 14():1223433. PubMed ID: 37662925
[TBL] [Abstract] [Full Text] [Related]
3. KRAS Pathways: A Potential Gateway for cancer Therapeutics and Diagnostics.
Tripathi PK; Mittal KR; Jain N; Sharma N; Jain CK
Recent Pat Anticancer Drug Discov; 2024; 19(3):268-279. PubMed ID: 37038676
[TBL] [Abstract] [Full Text] [Related]
4. An empirical review on the resistance mechanisms of epidermal growth factor receptor inhibitors and predictive molecular biomarkers in colorectal cancer.
Bhattacharya S
Crit Rev Oncol Hematol; 2023 Mar; 183():103916. PubMed ID: 36717006
[TBL] [Abstract] [Full Text] [Related]
5. Morbidity and long-term results in patients with wild and mutant type Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations undergoing colorectal cancer surgery.
Aziret M; Subasi O; Bilir C; Tozlu M; Altıntoprak F; Karaman K; Ercan M; Celebi F
Ann Ital Chir; 2022; 92():65-77. PubMed ID: 35342104
[TBL] [Abstract] [Full Text] [Related]
6. Molecular Pathways Associated with Kallikrein 6 Overexpression in colorectal cancer.
Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
[TBL] [Abstract] [Full Text] [Related]
7. Is the Effect of Tumor Localization on prognosis Compatible with Real-life Data in Metastatic Colon cancer? Single-Center Experience: A Retrospective Analysis.
Oytun MG; Bulut G; Gökmen E
J Gastrointest Cancer; 2022 Mar; 53(1):7-15. PubMed ID: 33665720
[TBL] [Abstract] [Full Text] [Related]
8. The role of circulating tumor cells and k-ras mutations in patients with locally advanced rectal cancer: a prospective study.
Bahnassy AA; Abdel-Azim YA; Ezzat S; Abdellateif MS; Zekri AN; Mohanad M; Salama A; Khaled H
Mol Biol Rep; 2020 Dec; 47(12):9645-9657. PubMed ID: 33174084
[TBL] [Abstract] [Full Text] [Related]
9. Small Molecule Destabilizer of β-Catenin and Ras Proteins Antagonizes Growth of k-ras Mutation-Driven colorectal cancers Resistant to EGFR Inhibitors.
Choi JK; Cho H; Moon BS
Target Oncol; 2020 Oct; 15(5):645-657. PubMed ID: 33026592
[TBL] [Abstract] [Full Text] [Related]
10. Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis.
Ye ZL; Qiu MZ; Tang T; Wang F; Zhou YX; Lei MJ; Guan WL; He CY
Cancer Med; 2020 Jan; 9(2):745-756. PubMed ID: 31782259
[TBL] [Abstract] [Full Text] [Related]
11. The prognostic significance of p63 cytoplasmic expression in colorectal cancer. An immunohistochemical study.
Albasri AM; Elkablawy MA; Ansari IA; Alhujaily AS; Khalil AA
Saudi Med J; 2019 May; 40(5):432-439. PubMed ID: 31056618
[TBL] [Abstract] [Full Text] [Related]
12. Development and validation of a novel prognostic score to predict survival in patients with metastatic colorectal cancer: the metastatic colorectal cancer score (mCCS).
Marschner N; Frank M; Vach W; Ladda E; Karcher A; Winter S; Jänicke M; Trarbach T
Colorectal Dis; 2019 Jul; 21(7):816-826. PubMed ID: 30834622
[TBL] [Abstract] [Full Text] [Related]
13. HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development.
Qian F; Xiao J; Gai L; Zhu J
Mol Carcinog; 2019 Apr; 58(4):500-510. PubMed ID: 30456802
[TBL] [Abstract] [Full Text] [Related]
14. Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group.
Goey KKH; Sørbye H; Glimelius B; Adams RA; André T; Arnold D; Berlin JD; Bodoky G; de Gramont A; Díaz-Rubio E; Eng C; Falcone A; Grothey A; Heinemann V; Hochster HS; Kaplan RS; Kopetz S; Labianca R; Lieu CH; Meropol NJ; Price TJ; Schilsky RL; Schmoll HJ; Shacham-Shmueli E; Shi Q; Sobrero AF; Souglakos J; Van Cutsem E; Zalcberg J; van Oijen MGH; Punt CJA; Koopman M
Eur J Cancer; 2018 Sep; 100():35-45. PubMed ID: 29936065
[TBL] [Abstract] [Full Text] [Related]
15. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
[TBL] [Abstract] [Full Text] [Related]
16. Bevacuzimab May Be Less Effective in Obese Metastatic colorectal cancer Patients.
Artaç M; Korkmaz L; Coşkun HŞ; Dane F; Karabulut B; Karaağaç M; Çabuk D; Karabulut S; Aykan NF; Doruk H; Avcı N; Turhal NS
J Gastrointest Cancer; 2019 Jun; 50(2):214-220. PubMed ID: 29302856
[TBL] [Abstract] [Full Text] [Related]
17. Critical Role of p53 and k-ras in the Diagnosis of Early colorectal cancer: a One-year, Single-center Analysis.
Lu HY; Lin RT; Zhou GX; Yu TM; Liu ZJ
Int J Med Sci; 2017; 14(11):1154-1162. PubMed ID: 29104470
[No Abstract] [Full Text] [Related]
18. Tumor regression grades, k-ras mutational profile and c-MET in colorectal liver metastases.
Lorenzon L; Ricca L; Pilozzi E; Lemoine A; Riggio V; Giudice MT; Mallel G; Fochetti F; Balducci G
Pathol Res Pract; 2017 Aug; 213(8):1002-1009. PubMed ID: 28559118
[TBL] [Abstract] [Full Text] [Related]
19. Transforming activity and therapeutic targeting of C-terminal-binding protein 2 in Apc-mutated neoplasia.
Sumner ET; Chawla AT; Cororaton AD; Koblinski JE; Kovi RC; Love IM; Szomju BB; Korwar S; Ellis KC; Grossman SR
Oncogene; 2017 Aug; 36(33):4810-4816. PubMed ID: 28414304
[TBL] [Abstract] [Full Text] [Related]
20. Familial pancreatic cancer: Concept, management and issues.
Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T
World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467
[TBL] [Abstract] [Full Text] [Related]
[Next]